Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Has results × Imlunestrant × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Breast Neoplasms 1

Interventions

Carboplatin 66 pembrolizumab 65 Specimen Handling 55 Magnetic Resonance Spectroscopy 52 Cisplatin 47 Paclitaxel 43 Nivolumab 42 Cyclophosphamide 42 Biopsy 41 Radiotherapy 33 Etoposide 33 Rituximab 32 Radiation 31 Lenalidomide 29 durvalumab 28 Doxorubicin 28 Dexamethasone 27 Docetaxel 25 olaparib 24 Ipilimumab 24 Gemcitabine 24 Taxes 23 Bevacizumab 23 Vincristine 21 Pemetrexed 21 Cytarabine 20 Prednisone 19 X-Rays 18 Disulfides 17 Platinum 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04975308 2025-07-11

EMBER-3

Eli Lilly and Company

Phase 3 Active not recruiting

874 enrolled 29 charts 1 FDA

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡